Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Caesarean birth

NICE guideline
Reference number: NG192
Published: 31 March 2021
Last updated: 30 January 2024

History

Guidance published

Consultation comments and responses (PDF 316 KB)

Published:

30 January 2024
Equality and health inequalities assessment (PDF 134 KB)

Published:

30 January 2024
Committee member list (PDF 174 KB)

Published:

30 January 2024

Stakeholder list updated

Stakeholder list (PDF 141 KB)

Published:

29 January 2024

Declaration of interests

Register of interests (PDF 1.24 MB)

Published:

29 January 2024

Draft guidance consultation

Draft guidance consultation
Comments form (MSWord 40 KB)

Published:

28 November 2023
Equality impact assessment 3 (PDF 120 KB)

Published:

28 November 2023
Evidence review (PDF 3.64 MB)

Published:

28 November 2023
Draft guideline (PDF 178 KB)

Published:

28 November 2023

Committee meetings

Committee meeting
Minutes 1 (PDF 253 KB)

Published:

06 March 2023
Minutes 2 (PDF 182 KB)

Published:

18 July 2023
Minutes 3 (PDF 223 KB)

Published:

27 September 2023
Minutes 4 (PDF 208 KB)

Published:

13 December 2023

Scope published

Final scope (PDF 212 KB)

Published:

14 July 2023

Update on 06 September 2023

Guidance published
Consultation comments and responses (PDF 368 KB)

Published:

06 September 2023
Equality impact assessment Final (PDF 148 KB)

Published:

06 September 2023
Committee member list (PDF 178 KB)

Published:

06 September 2023
Stakeholder list updated
Stakeholder list (PDF 142 KB)

Published:

05 September 2023
Declaration of interests
Register of interests (PDF 1.14 MB)

Published:

26 June 2023
Draft guidance consultation
Draft guidance consultation
Equality impact assessment 3 (PDF 117 KB)

Published:

04 July 2023
Comments form (MSWord 42 KB)

Published:

04 July 2023
Supporting documentation (PDF 224 KB)

Published:

04 July 2023
Committee member list (PDF 178 KB)

Published:

04 July 2023
Scope published
Final scope (PDF 212 KB)

Published:

14 July 2023
Committee meeting
Minutes 1 (PDF 253 KB)

Published:

06 March 2023
Minutes 2 (PDF 245 KB)

Published:

03 May 2023

Update on 23 August 2023

Guidance published
Consultation comments and responses (PDF 281 KB)

Published:

23 August 2023
Equality impact assessment Final (PDF 145 KB)

Published:

23 August 2023
Committee member list (PDF 178 KB)

Published:

23 August 2023
Stakeholder list updated
Stakeholder list (PDF 142 KB)

Published:

22 August 2023
Draft guidance consultation
Draft guidance consultation
Comments form (MSWord 42 KB)

Published:

04 July 2023
Equality impact assessment (PDF 118 KB)

Published:

04 July 2023
Evidence review (PDF 2.03 MB)

Published:

04 July 2023
Supporting documentation (PDF 145 KB)

Published:

04 July 2023
Committee member list (PDF 178 KB)

Published:

04 July 2023
Scope published
Final scope (PDF 212 KB)

Published:

14 July 2023
Declaration of interests
Committee meeting
Minutes 1 (PDF 253 KB)

Published:

06 March 2023
Minutes 2 (PDF 245 KB)

Published:

03 May 2023

Update on 21 June 2023

Guidance published
Consultation comments and responses (PDF 621 KB)

Published:

21 June 2023
Equality impact assessment 4 (PDF 155 KB)

Published:

21 June 2023
Stakeholder list updated
Stakeholder list (PDF 113 KB)

Published:

20 June 2023
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 152 KB)

Published:

02 May 2023
Equality impact assessment 3 (PDF 125 KB)

Published:

02 May 2023
Comments form (MSWord 41 KB)

Published:

02 May 2023
Committee list updated
Committee member list (PDF 178 KB)

Published:

12 April 2023
Declaration of interests
Register of interests (PDF 1.01 MB)

Published:

18 April 2023

Original development on 31 March 2021

Guidance published
Equality impact assessment 4 (PDF 108 KB)

Published:

31 March 2021
Committee member list (PDF 150 KB)

Published:

31 March 2021
Consultation comments and responses (PDF 2.14 MB)

Published:

31 March 2021
Stakeholder list updated
Stakeholder list (PDF 167 KB)

Published:

31 March 2021
Declaration of interests
Register of interests (PDF 533 KB)

Published:

31 March 2021
Committee list updated
Committee member list (PDF 152 KB)

Published:

15 March 2021
Equality and health inequalities assessment
Equality impact assessment 4 (MSWord 31 KB)

Published:

15 February 2021
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF version) (PDF 906 KB)

Published:

15 October 2020
Equality impact assessment 3 (PDF 111 KB)

Published:

15 October 2020
Comments form (MSWord 43 KB)

Published:

15 October 2020
Evidence review A - benefits and risks (PDF 1.9 MB)

Published:

15 October 2020
Evidence review B - techniques to reduce infectious morbidity (PDF 1.33 MB)

Published:

15 October 2020
Evidence review C - prevent shivering (PDF 2.55 MB)

Published:

15 October 2020
Evidence review D - uterine closure (PDF 1.2 MB)

Published:

15 October 2020
Evidence review E - monitoring (PDF 522 KB)

Published:

15 October 2020
Evidence review F - pain relief (PDF 1.11 MB)

Published:

15 October 2020
Committee member list (PDF 146 KB)

Published:

15 October 2020
Supporting documentation Methods (PDF 441 KB)

Published:

15 October 2020
Supporting documentation Glossary & abbreviations (PDF 471 KB)

Published:

15 October 2020
Supporting documentation NGA staff (PDF 160 KB)

Published:

15 October 2020
Supporting documentation CG132 full guideline (PDF 4.33 MB)

Published:

15 October 2020
Supporting documentation CG132 appendices A-K (PDF 6.94 MB)

Published:

15 October 2020
Supporting documentation CG132 appendix G (PDF 5.43 MB)

Published:

15 October 2020
Stakeholder list (PDF 44 KB)

Published:

15 October 2020
Supporting documentation (PDF 526 KB)

Published:

15 October 2020
Pre-consultation documents released
Review questions (PDF 184 KB)

Published:

20 August 2020
Economic plan (PDF 89 KB)

Published:

20 August 2020
Search strategies (PDF 2.25 MB)

Published:

20 August 2020
Scope published
Final scope (PDF 277 KB)

Published:

15 November 2019
Committee meeting
Minutes 1 (PDF 389 KB)

Published:

02 February 2018
Minutes 2 (PDF 320 KB)

Published:

02 May 2018
Minutes 3 (PDF 315 KB)

Published:

23 July 2018
Minutes 4 (PDF 263 KB)

Published:

05 September 2018
Minutes 5 (PDF 260 KB)

Published:

01 November 2018
Minutes 6 (PDF 206 KB)

Published:

11 December 2018
Minutes 7 (PDF 212 KB)

Published:

29 January 2019
Minutes 8 (PDF 182 KB)

Published:

19 March 2019
Minutes 9 (PDF 194 KB)

Published:

25 September 2019
Minutes 10 (PDF 206 KB)

Published:

25 October 2019
Minutes 11 (PDF 236 KB)

Published:

24 January 2020
Minutes 12 (PDF 182 KB)

Published:

13 July 2020
Minutes 13 (PDF 179 KB)

Published:

15 October 2020
Minutes 14 (MSWord 112 KB)

Published:

18 December 2020